Search Results

Empagliflozin 200 mg  | 99.89%

TargetMol

Empagliflozin is a Sodium-Glucose Cotransporter 2 Inhibitor. The mechanism of action of empagliflozin is as a Sodium-Glucose Transporter 2 Inhibitor.

More Information Supplier Page

Obeticholic Acid 200 mg  | 99.78%

TargetMol

Obeticholic Acid (6-ECDCA) is a Farnesoid X Receptor Agonist. The mechanism of action of obeticholic acid is as a Farnesoid X Receptor Agonist.

More Information Supplier Page

Clemizole hydrochloride 25 mg  | 99.91%

TargetMol

Clemizole hydrochloride is an antagonist for H1 histamine receptor. According to the research, Clemizole hydrochloride can inhibit hepatitis C virus (HCV) replication and NS4B’s RNA binding.

More Information Supplier Page

GSK 3 Inhibitor IX 100 mg  | 99.90%

TargetMol

GSK 3 Inhibitor IX (6-BIO) is a selective reversible, ATP-competitive inhibitor of GSK-3α/β and CDK1-cyclinB complex. It inhibits (GSK-3α/β)/CDK1/CDK5 activity with IC50 values of 5 nM/320 nM/83 nM, respectively.

More Information Supplier Page

GSK 3 Inhibitor IX 25 mg  | 99.90%

TargetMol

GSK 3 Inhibitor IX (6-BIO) is a selective reversible, ATP-competitive inhibitor of GSK-3α/β and CDK1-cyclinB complex. It inhibits (GSK-3α/β)/CDK1/CDK5 activity with IC50 values of 5 nM/320 nM/83 nM, respectively.

More Information Supplier Page

GSK 3 Inhibitor IX 2 mg  | 99.90%

TargetMol

GSK 3 Inhibitor IX (6-BIO) is a selective reversible, ATP-competitive inhibitor of GSK-3α/β and CDK1-cyclinB complex. It inhibits (GSK-3α/β)/CDK1/CDK5 activity with IC50 values of 5 nM/320 nM/83 nM, respectively.

More Information Supplier Page